CLRPF
Price
$2.85
Change
-$0.32 (-10.09%)
Updated
Aug 7 closing price
Capitalization
1.05B
SBHMY
Price
$18.65
Change
+$1.15 (+6.57%)
Updated
Jul 28 closing price
Capitalization
16.62B
Interact to see
Advertisement

CLRPF vs SBHMY

Header iconCLRPF vs SBHMY Comparison
Open Charts CLRPF vs SBHMYBanner chart's image
Clarity Pharmaceuticals
Price$2.85
Change-$0.32 (-10.09%)
Volume$6.87K
Capitalization1.05B
Sino Biopharmaceutical
Price$18.65
Change+$1.15 (+6.57%)
Volume$1.03K
Capitalization16.62B
CLRPF vs SBHMY Comparison Chart in %
Loading...
CLRPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBHMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLRPF vs. SBHMY commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLRPF is a Hold and SBHMY is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (CLRPF: $2.85 vs. SBHMY: $18.65)
Brand notoriety: CLRPF and SBHMY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLRPF: 89% vs. SBHMY: 299%
Market capitalization -- CLRPF: $1.05B vs. SBHMY: $16.62B
CLRPF [@Biotechnology] is valued at $1.05B. SBHMY’s [@Biotechnology] market capitalization is $16.62B. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLRPF’s FA Score shows that 0 FA rating(s) are green whileSBHMY’s FA Score has 3 green FA rating(s).

  • CLRPF’s FA Score: 0 green, 5 red.
  • SBHMY’s FA Score: 3 green, 2 red.
According to our system of comparison, SBHMY is a better buy in the long-term than CLRPF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLRPF’s TA Score shows that 3 TA indicator(s) are bullish while SBHMY’s TA Score has 1 bullish TA indicator(s).

  • CLRPF’s TA Score: 3 bullish, 3 bearish.
  • SBHMY’s TA Score: 1 bullish, 3 bearish.
According to our system of comparison, CLRPF is a better buy in the short-term than SBHMY.

Price Growth

CLRPF (@Biotechnology) experienced а +0.18% price change this week, while SBHMY (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SBHMY($16.6B) has a higher market cap than CLRPF($1.05B). SBHMY YTD gains are higher at: 128.675 vs. CLRPF (5.360). SBHMY has higher annual earnings (EBITDA): 6.89B vs. CLRPF (-66.98M).
CLRPFSBHMYCLRPF / SBHMY
Capitalization1.05B16.6B6%
EBITDA-66.98M6.89B-1%
Gain YTD5.360128.6754%
P/E RatioN/A63.82-
RevenueN/A28.9B-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
SBHMY: Fundamental Ratings
SBHMY
OUTLOOK RATING
1..100
36
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
27
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
7
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLRPFSBHMY
RSI
ODDS (%)
Bearish Trend 1 day ago
65%
N/A
Stochastic
ODDS (%)
N/A
Bearish Trend 1 day ago
38%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
33%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
33%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
36%
Advances
ODDS (%)
Bullish Trend 3 days ago
83%
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
68%
Bearish Trend 1 day ago
50%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
39%
View a ticker or compare two or three
Interact to see
Advertisement
CLRPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SBHMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MEMIX41.48N/A
N/A
MFS Emerging Markets Equity I
NSRIX25.07N/A
N/A
Northern World Selection Index I
SSTFX11.41N/A
N/A
Virtus KAR Capital Growth C
MAPLX29.42N/A
N/A
Morgan Stanley Inst Advantage L
GCEGX9.74N/A
N/A
Goldman Sachs Clean Energy Income C

CLRPF and

Correlation & Price change

A.I.dvisor tells us that CLRPF and SBHMY have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLRPF and SBHMY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLRPF
1D Price
Change %
CLRPF100%
-10.09%
SBHMY - CLRPF
24%
Poorly correlated
N/A
BOLD - CLRPF
23%
Poorly correlated
-3.39%
AKBA - CLRPF
21%
Poorly correlated
-20.48%
DOSEF - CLRPF
12%
Poorly correlated
N/A
ACUT - CLRPF
9%
Poorly correlated
+4.37%
More

SBHMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SBHMY has been loosely correlated with TENX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SBHMY jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBHMY
1D Price
Change %
SBHMY100%
N/A
TENX - SBHMY
42%
Loosely correlated
-2.13%
SYBX - SBHMY
34%
Loosely correlated
-1.38%
BTAI - SBHMY
32%
Poorly correlated
+2.71%
CLRPF - SBHMY
24%
Poorly correlated
-10.09%
VIVS - SBHMY
20%
Poorly correlated
-2.40%
More